Biosergen
36.80 SEK
-4.17 %
Less than 1K followers
BIOSGN
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Biosergen
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -4.4 | -1.7 | -18.6 | -5.1 | -11.0 | -12.2 | -12.5 | -40.9 |
| EBIT | -4.4 | -1.7 | -18.6 | -5.1 | -11.0 | -12.2 | -12.5 | -40.9 |
| EBIT-% | ||||||||
| Profit before taxes | -4.3 | -1.8 | -18.8 | -5.2 | -11.0 | -12.2 | -12.5 | -40.8 |
| Net income | -4.3 | -1.8 | -18.8 | -5.2 | -11.0 | -12.2 | -12.5 | -40.8 |